DNA Methylation Predicts Adverse Outcomes of Coronary Artery Disease
Min Qin, Qili Wu, Xiaoxue Tian, Qian Zhu, Xianhong Fang, Xiaoping Chen, Chen Liu, Bin Zhang, Hanping Li, Xipei Wang, Cuiping Pan, Shilong Zhong
doi: https://doi.org/10.1101/2023.10.07.23296703
Min Qin
1Department of Pharmacy, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
2Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
3School of Medicine, South China University of Technology, Guangzhou, China
8Center for Intelligent Medicine Research, Greater Bay Area Institute of Precision Medicine (Guangzhou), School of Life Sciences, Fudan University, Guangzhou, China
Qili Wu
1Department of Pharmacy, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
2Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
Xiaoxue Tian
1Department of Pharmacy, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
2Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
Qian Zhu
1Department of Pharmacy, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
2Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
Xianhong Fang
4Department of Cardiology, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
Xiaoping Chen
5Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China
Chen Liu
6Department of Cardiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, Guangdong, China
Bin Zhang
4Department of Cardiology, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
Hanping Li
2Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
Xipei Wang
7Laboratory of Phase I Clinical Trials, Medical Research Center of Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
Cuiping Pan
8Center for Intelligent Medicine Research, Greater Bay Area Institute of Precision Medicine (Guangzhou), School of Life Sciences, Fudan University, Guangzhou, China
9Center for Evolutionary Biology, Fudan University, Shanghai, China
Shilong Zhong
1Department of Pharmacy, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
2Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
3School of Medicine, South China University of Technology, Guangzhou, China
7Laboratory of Phase I Clinical Trials, Medical Research Center of Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
Article usage
Posted October 09, 2023.
DNA Methylation Predicts Adverse Outcomes of Coronary Artery Disease
Min Qin, Qili Wu, Xiaoxue Tian, Qian Zhu, Xianhong Fang, Xiaoping Chen, Chen Liu, Bin Zhang, Hanping Li, Xipei Wang, Cuiping Pan, Shilong Zhong
medRxiv 2023.10.07.23296703; doi: https://doi.org/10.1101/2023.10.07.23296703
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (695)
- Anesthesia (187)
- Cardiovascular Medicine (2817)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12506)
- Forensic Medicine (10)
- Gastroenterology (797)
- Genetic and Genomic Medicine (4372)
- Geriatric Medicine (398)
- Health Economics (711)
- Health Informatics (2821)
- Health Policy (1042)
- Hematology (372)
- HIV/AIDS (889)
- Medical Education (412)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4140)
- Nursing (219)
- Nutrition (614)
- Oncology (2178)
- Ophthalmology (618)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (261)
- Palliative Medicine (81)
- Pathology (482)
- Pediatrics (1166)
- Primary Care Research (480)
- Public and Global Health (6725)
- Radiology and Imaging (1477)
- Respiratory Medicine (893)
- Rheumatology (429)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (198)
- Urology (173)